{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:01:43Z","timestamp":1770980503678,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,2,21]],"date-time":"2014-02-21T00:00:00Z","timestamp":1392940800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s10067-014-2536-z","type":"journal-article","created":{"date-parts":[[2014,2,20]],"date-time":"2014-02-20T01:33:28Z","timestamp":1392860008000},"page":"543-547","source":"Crossref","is-referenced-by-count":29,"title":["The use of TNF-\u03b1 blockers in psoriatic arthritis patients with latent tuberculosis infection"],"prefix":"10.1007","volume":"33","author":[{"given":"Mariangela","family":"Atteno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Matarese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Caso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Del Puente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luisa","family":"Bocchino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Sanduzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,21]]},"reference":[{"key":"2536_CR1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","volume":"3","author":"JM Moll","year":"1973","unstructured":"Moll JM, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3:55\u201378","journal-title":"Semin Arthritis Rheum"},{"key":"2536_CR2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3899\/jrheum.110845","volume":"39","author":"W Tillett","year":"2012","unstructured":"Tillett W, Costa L, Jadon D, Wallis D, Cavill C, McHugh J, Korendowych E, McHugh N (2012) The ClASsification for Psoriatic ARthritis (CASPAR) criteria\u2014a retrospective feasibility, sensitivity, and specificity study. J Rheumatol 39:154\u2013156","journal-title":"J Rheumatol"},{"key":"2536_CR3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3899\/jrheum.120243","volume":"89","author":"E Soscia","year":"2012","unstructured":"Soscia E, Sirignano C, Catalano O, Atteno M, Costa L, Caso F, Peluso R, Bruner V, Aquino MM, Del Puente A, Salvatore M, Scarpa R (2012) New developments in magnetic resonance imaging of the nail unit. J Rheumatol Suppl 89:49\u201353","journal-title":"J Rheumatol Suppl"},{"key":"2536_CR4","first-page":"1241","volume":"27","author":"R Scarpa","year":"2000","unstructured":"Scarpa R, Manguso F, D\u2019Arienzo A, D\u2019Armiento FP, Astarita C, Mazzacca G, Ayala F (2000) Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms. J Rheumatol 27:1241\u20131246","journal-title":"J Rheumatol"},{"key":"2536_CR5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10067-011-1892-1","volume":"31","author":"L Costa","year":"2012","unstructured":"Costa L, Caso F, D\u2019Elia L, Atteno M, Peluso R, Del Puente A, Strazzullo P, Scarpa R (2012) Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study. Clin Rheumatol 31:711\u2013715","journal-title":"Clin Rheumatol"},{"key":"2536_CR6","author":"L Costa","year":"2013","unstructured":"Costa L, Caso F, Atteno M, Del Puente A, Darda MA, Caso P, Ortolan A, Fiocco U, Ramonda R, Punzi L, Scarpa R (2013) Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients. Clin Rheumatol. doi: 10.1007\/s10067-013-2378-0","journal-title":"Clin Rheumatol"},{"key":"2536_CR7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10067-009-1340-7","volume":"29","author":"M Atteno","year":"2010","unstructured":"Atteno M, Peluso R, Costa L, Padula S, Iervolino S, Caso F, Sanduzzi A, Lubrano E, Del Puente A, Scarpa R (2010) Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs. Clin Rheumatol 29:399\u2013403","journal-title":"Clin Rheumatol"},{"key":"2536_CR8","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s10067-011-1680-y","volume":"30","author":"R Scarpa","year":"2011","unstructured":"Scarpa R, Atteno M, Lubrano E, Provenzano G, D\u2019Angelo S, Spadaro A, Costa L, Olivieri I (2011) The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: an Italian multicentre longitudinal observational pilot study. Clin Rheumatol 30:1063\u20131067","journal-title":"Clin Rheumatol"},{"key":"2536_CR9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jbspin.2012.06.016","volume":"80","author":"U Fiocco","year":"2013","unstructured":"Fiocco U, Sfriso P, Oliviero F, Lunardi F, Calabrese F, Scagliori E, Cozzi L, Di Maggio A, Nardacchione R, Molena B, Felicetti M, Gazzola K, Stramare R, Rubaltelli L, Accordi B, Costa L, Roux-Lombard P, Punzi L, Dayer JM (2013) Blockade of intra-articular TNF in peripheral spondyloarthritis: its relevance to clinical scores, quantitative imaging and synovial fluid and synovial tissue biomarkers. Jt Bone Spine 80:165\u2013170","journal-title":"Jt Bone Spine"},{"key":"2536_CR10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10067-013-2378-0","volume":"33","author":"L Costa","year":"2014","unstructured":"Costa L, Caso F, Atteno M, Giannitti C, Spadaro A, Ramonda R, Vezz\u00f9 M, Del Puente A, Morisco F, Fiocco U, Galeazzi M, Punzi L, Scarpa R (2014) Long-term safety of anti-TNF-\u03b1 in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients. Clin Rheumatol 33:273\u2013276","journal-title":"Clin Rheumatol"},{"key":"2536_CR11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3899\/jrheum.090233","volume":"83","author":"B Bellofiore","year":"2009","unstructured":"Bellofiore B, Matarese A, Balato N, Gaudiello F, Scarpa R, Atteno M, Bocchino M, Sanduzzi A (2009) Prevention of tuberculosis in patients taking tumor necrosis factor-alpha blockers. J Rheumatol Suppl 83:76\u201377","journal-title":"J Rheumatol Suppl"},{"key":"2536_CR12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","volume":"282","author":"C Dye","year":"1999","unstructured":"Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC (1999) Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282:677\u2013686","journal-title":"JAMA"},{"key":"2536_CR13","first-page":"120","volume":"88","author":"V Kindler","year":"1991","unstructured":"Kindler V, Sappino AP (1991) The beneficial effects of localized tumor necrosis factor production in BCG infection. Behring Inst Mitt 88:120\u2013124","journal-title":"Behring Inst Mitt"},{"key":"2536_CR14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1568-9972(03)00048-X","volume":"2","author":"AG Suryaprasad","year":"2003","unstructured":"Suryaprasad AG, Prindiville T (2003) The biology of TNF blockade. Autoimmun Rev 2:346\u2013357","journal-title":"Autoimmun Rev"},{"key":"2536_CR15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3899\/jrheum.120252","volume":"89","author":"A Sanduzzi","year":"2012","unstructured":"Sanduzzi A, Bocchino M, Atteno M, Costa L, Ponticiello A, Matarese A, Span\u00f2 A, Bruner V, Peluso R, Aquino MM, Del Puente A, Scarpa R (2012) Screening and monitoring of latent tubercular infection in patients taking tumor necrosis factor-\u03b1 blockers for psoriatic arthritis. J Rheumatol Suppl 89:82\u201385","journal-title":"J Rheumatol Suppl"},{"issue":"Suppl 1","key":"2536_CR16","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1136\/ard.2009.123885","volume":"69","author":"DE Furst","year":"2010","unstructured":"Furst DE, Keystone EC, Fleischmann R, Mease P, Breedveld FC, Smolen JS, Kalden JR, Braun J, Bresnihan B, Burmester GR, De Benedetti F, D\u00f6rner T, Emery P, Gibofsky A, Kavanaugh A, Kirkham B, Schiff MH, Sieper J, Singer N, Van Riel PL, Weinblatt ME, Weisman MH, Winthrop K (2010) Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009. Ann Rheum Dis 69(Suppl 1):i2\u2013i29","journal-title":"Ann Rheum Dis"},{"key":"2536_CR17","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/art.21978","volume":"54","author":"WG Dixon","year":"2006","unstructured":"Dixon WG, Watson K, Lunt M, Hyrich KL, Silman AJ, Symmons DP, British Society for Rheumatology Biologics Register (2006) Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 54:2368\u201376","journal-title":"Arthritis Rheum"},{"key":"2536_CR18","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.4049\/jimmunol.168.7.3394","volume":"168","author":"ML Olleros","year":"2002","unstructured":"Olleros ML, Guler R, Corazza N, Vesin D, Eugster HP, Marchal G, Chavarot P, Mueller C, Garcia I (2002) Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Gu\u00e9rin infection in the absence of secreted TNF and lymphotoxin-alpha. J Immunol 168:3394\u20133401","journal-title":"J Immunol"},{"key":"2536_CR19","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","volume":"48","author":"JJ G\u00f3mez-Reino","year":"2003","unstructured":"G\u00f3mez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD, BIOBADASER Group (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48:2122\u20137","journal-title":"Arthritis Rheum"},{"key":"2536_CR20","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345:1098\u20131104","journal-title":"N Engl J Med"},{"key":"2536_CR21","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/rheumatology\/keh567","volume":"44","author":"J Keane","year":"2005","unstructured":"Keane J (2005) TNF-blocking agents and tuberculosis: new drugs illuminate an old topic. Rheumatology (Oxford) 44:714\u2013720","journal-title":"Rheumatology (Oxford)"},{"issue":"RR-6","key":"2536_CR22","first-page":"1","volume":"49","author":"American Thoracic Society","year":"2000","unstructured":"American Thoracic Society (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 49(RR-6):1\u201351","journal-title":"MMWR Recomm Rep"},{"key":"2536_CR23","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1086\/314037","volume":"31","author":"SA Gilroy","year":"2000","unstructured":"Gilroy SA, Gilroy SA, Rogers MA, Blair DC (2000) Treatment of latent tuberculosis infection in patients aged > or =35 years. Clin Infect Dis 31:826\u2013829","journal-title":"Clin Infect Dis"},{"key":"2536_CR24","author":"V Valls","year":"2014","unstructured":"Valls V, Ena J (2014) Short-course treatment of latent tuberculosis infection in patients with rheumatic conditions proposed for anti-TNF therapy. Clin Rheumatol. doi: 10.1007\/s10067-014-2495-4","journal-title":"Clin Rheumatol"},{"key":"2536_CR25","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/art.24632","volume":"60","author":"F Tubach","year":"2009","unstructured":"Tubach F, Salmon D, Ravaud P, Allanore Y, Goupille P, Br\u00e9ban M, Pallot-Prades B, Pouplin S, Sacchi A, Chichemanian RM, Bretagne S, Emilie D, Lemann M, Lortholary O, Mariette X, Research Axed on Tolerance of Biotherapies Group (2009) Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French Research Axed on Tolerance of Biotherapies registry. Arthritis Rheum 60:1884\u20131894","journal-title":"Arthritis Rheum"},{"key":"2536_CR26","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ard.2009.118935","volume":"69","author":"WG Dixon","year":"2010","unstructured":"Dixon WG, Hyrich KL, Watson KD, Lunt M, Galloway J, Ustianowski A, B S R B R Control Centre Consortium, Symmons DP, BSR Biologics Register (2010) Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR). Ann Rheum Dis 69:522\u2013528","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2536-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-014-2536-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2536-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T22:52:17Z","timestamp":1553640737000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-014-2536-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,21]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["2536"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2536-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,21]]}}}